COMMUNIQUÉS West-GlobeNewswire

POSSIBLE® by Standard Process® Launches Peanut Butter Banana Cacao Snack Bar
27/08/2026
A Whole Food Snack Bar Designed to Support Real Life PALMYRA, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- POSSIBLE ® by Standard Process ® today announced the launch of its new POSSIBLE ® Peanut Butter Banana Cacao Snack [...]
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
27/08/2026
Video webcast now available here OCALA, Fla., Aug. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it participated in the Virtual Investor "Why Now" on [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27/08/2026
Video webcast now available here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ ( [...]
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel [...]
GRI Bio Featured in "Why Now" On-Demand Video Webcast
27/08/2026
Video webcast now available here LA JOLLA, CA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, [...]
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here CAMBRIDGE, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and [...]
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
- Video webcast now available here HOUSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it participated in the Virtual Investor “Why [...]
L’étude Can-RISE nationale aide à combler les lacunes en recherche sur la ménopause
27/08/2026
En collaboration avec GreenShield et à travers une subvention philanthropique d’Organon, les personnes admissibles sont désormais invitées à prendre part à la première étude nationale menée par des chercheurs reposant [...]
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
27/08/2026
The first national investigator-led study focused on Canadian women’s experiences of menopause and the menopausal transition is now inviting participants, in partnership with GreenShield and supported by a charitable [...]
CalciMedica Announces One-for-Five Reverse Stock Split
27/08/2026
CalciMedica’s Common Stock to Begin Trading on a Post-Split Adjusted Basis on August 31, 2026 LA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a [...]
Power to Decide Announces Lori Adelman as Chief Executive Officer
27/08/2026
Washington, D.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Today, Power to Decide announces that Lori Adelman will join the organization as Chief Executive Officer, effective September 14, 2026. Adelman brings nearly two [...]
Codexis to Participate in Cantor Global Healthcare Conference 2026
27/08/2026
REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the [...]
argenx Completes Acquisition of Forte Biosciences, Inc.
27/08/2026
Acquisition adds first-in-class anti-CD122 Antibody, FB102, to argenx’s immunology pipeline August 27, 2026 – 8:50 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation [...]
Orion Corporation to commence acquisition of own shares for its share-based incentive plans
27/08/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 AUGUST 2026 at 13.00 EEST Orion Corporation to commence acquisition of own shares for its share-based [...]
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
27/08/2026
Paris, France - August 27, 2026 – HighLife SAS, a medical technology company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral [...]
Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU
27/08/2026
Combines Osivax's proprietary OVX836 T-cell vaccine and technology with GC Biopharma's marketed influenza vaccine and worldwide manufacturing expertise Positions Osivax as the global development lead for a [...]
hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets
27/08/2026
London, UK – 27 August 2026 , hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition of CRS Clinical [...]
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
27/08/2026
MELBOURNE, Australia and NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced its tenth consecutive annual profit and further rise in free cash in the [...]

Pages